- Home
- st kitts nevis
- Equipment
Show results for
Refine by
Applications
- Endoform - Antimicrobial and Natural Restorative Bioscaffold for Negative Pressure Wound Therapy
- Medical Device for Clinicians
- Medical Device for Patients
- Advanced Wound Matrix for Surgical and Incisional Wound Management
- Advanced Wound Matrix for Providers
- Advanced Wound Matrix for Patient Information
- Advanced Wound Matrix for Pre-Clinical Study
- Dental Units for Dental Unit Water Lines
- Antimicrobial Shield Technology for Urgent Clinical Need
- Ultrasound Therapy Machine
- Personal Ultrasound Machine for Pain
- Myriad Matrix - Engineered Extracellular Matrix for Hidradenitis SuppurativaClinical Resource
- Wound Therapy Applications Device for Mixed Aetiology Leg Ulcers
- Wound Therapy Applications Device for Venous Leg Ulcers
- Exosomes - Extracellular Vesicles for Validation and Quality Control
- Exosomes - Extracellular Vesicles for Cancer Treatment
- Exosomes - Extracellular Vesicles for Immunomodulating Response
- Exosomes - Extracellular Vesicles for Molecular Therapy
- Exosomes - Extracellular Vesicles for Brain Drug Delivery
- Exosomes - Extracellular Vesicles for Ocular Drug Delivery
Zymeworks Medical Equipment & Supplies Near St Kitts Nevis
2 equipment items found
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
using precise antibody Fc modifications that tailor the antibody-mediated immune response. Get the optimal response. Tailor immune system response for a desired therapeutic effect using the Effector Function Enhancement and Control Technology’s (EFECT™) library of Fc region modifications. The EFECT™ library includes proprietary mutations to the CH2 domain of the antibody's Fc ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
ZW49 is a HER2-targeted antibody drug conjugate (ADC) developed using Zymeworks’ proprietary Azymetric™ and ZymeLink™ platforms. ZW49 is currently being evaluated in a Phase 1 clinical trial as a treatment for patients with locally advanced or metastatic HER2-expressing cancers that have progressed following treatment with existing approved therapies, including HER2-targeted ...